Sonoma Pharmaceuticals (STU:O8Z3) FCF Margin % : -35.20% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Sonoma Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Sonoma Pharmaceuticals's Free Cash Flow for the three months ended in Dec. 2023 was €-1.01 Mil. Sonoma Pharmaceuticals's Revenue for the three months ended in Dec. 2023 was €2.88 Mil. Therefore, Sonoma Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2023 was -35.20%.

As of today, Sonoma Pharmaceuticals's current FCF Yield % is -176.31%.

The historical rank and industry rank for Sonoma Pharmaceuticals's FCF Margin % or its related term are showing as below:

STU:O8Z3' s FCF Margin % Range Over the Past 10 Years
Min: -97.03 Med: -48.85 Max: -19.09
Current: -42.39

During the past 13 years, the highest FCF Margin % of Sonoma Pharmaceuticals was -19.09%. The lowest was -97.03%. And the median was -48.85%.

STU:O8Z3's FCF Margin % is ranked worse than
83.93% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.03 vs STU:O8Z3: -42.39

Sonoma Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Sonoma Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sonoma Pharmaceuticals FCF Margin % Chart

Sonoma Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Margin %

Get a 7-Day Free Trial

-62.30

-26.76

-19.10

-34.72

-48.38

Sonoma Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-12.88	-87.28	-6.77	-45.13	-35.20

Competitive Comparison of Sonoma Pharmaceuticals's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Sonoma Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sonoma Pharmaceuticals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sonoma Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Sonoma Pharmaceuticals's FCF Margin % falls into.

Sonoma Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Sonoma Pharmaceuticals's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	-5.997	/	12.396
	=	-48.38 %

Sonoma Pharmaceuticals's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-1.013	/	2.878
	=	-35.20 %

Sonoma Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Sonoma Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sonoma Pharmaceuticals (STU:O8Z3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sonoma Pharmaceuticals Inc (STU:O8Z3) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

SNOA:USA

Address

5445 Conestoga Court, Suite 150, Boulder, CO, USA, 80301

Website

https://www.sonomapharma.com

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, and other countries.

Sonoma Pharmaceuticals (STU:O8Z3) Headlines

No Headlines